Details of Host Protein
| Host Protein General Information (ID: PT1261) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein Name | YTH domain-containing family protein 2 (YTHDF2) 
             | Gene Name | YTHDF2 
             | ||||||
| Host Species | Homo sapiens 
             | Uniprot Entry Name | YTHD2_HUMAN 
             | ||||||
| Protein Families | YTHDF family 
             | ||||||||
| Subcellular Location | Cytoplasm; cytosol Cytoplasm; P-body Cytoplasm 
             | ||||||||
| External Link | |||||||||
| NCBI Gene ID | |||||||||
| Uniprot ID | |||||||||
| Ensembl ID | |||||||||
| HGNC ID | |||||||||
| Function in Host | 
              Specifically recognizes and binds N6-methyladenosine (m6A) -containing RNAs, and regulates their stability. M6A is amodification present at internal sites of mRNAs and some non-codingRNAs and plays a role in mRNA stability and processing. Acts as a regulator of mRNA stability by promotingdegradation of m6A-containing mRNAs via interaction with the CCR4-NOTand ribonuclease P/MRP complexes, depending on the context. The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) sharem6A-containing mRNAs targets and act redundantly to mediate mRNAdegradation and cellular differentiation. M6A-containing mRNAs containing a binding site forRIDA/HRSP12 (5'-GGUUC-3') are preferentially degraded byendoribonucleolytic cleavage: cooperative binding of RIDA/HRSP12 andYTHDF2 to transcripts leads to recruitment of the ribonuclease P/MRPcomplex. Other m6A-containing mRNAs undergodeadenylation via direct interaction between YTHDF2 and CNOT1, leadingto recruitment of the CCR4-NOT and subsequent deadenylation of m6A-containing mRNAs. Required maternally to regulateoocyte maturation: probably acts by binding to m6A-containing mRNAs, thereby regulating maternal transcript dosage during oocyte maturation, which is essential for the competence of oocytes to sustain earlyzygotic development. Also required duringspermatogenesis: regulates spermagonial adhesion by promotingdegradation of m6A-containing transcripts coding for matrixmetallopeptidases. Also involved in hematopoietic stemcells specification by binding to m6A-containing mRNAs, leading topromote their degradation. Also acts as a regulatorof neural development by promoting m6A-dependent degradation of neuraldevelopment-related mRNA targets. Inhibits neuralspecification of induced pluripotent stem cells by binding tomethylated neural-specific mRNAs and promoting their degradation, thereby restraining neural differentiation. Regulatescircadian regulation of hepatic lipid metabolism: acts by promotingm6A-dependent degradation of PPARA transcripts. Regulates the innate immune response to infection by inhibiting thetype I interferon response: acts by binding to m6A-containing IFNBtranscripts and promoting their degradation. May alsoact as a promoter of cap-independent mRNA translation following heatshock stress: upon stress, relocalizes to the nucleus and specificallybinds mRNAs with some m6A methylation mark at their 5'-UTR, protectingdemethylation of mRNAs by FTO, thereby promoting cap-independent mRNAtranslation. Regulates mitotic entry by promoting thephase-specific m6A-dependent degradation of WEE1 transcripts. Promotes formation of phase-separated membranelesscompartments, such as P-bodies or stress granules, by undergoingliquid-liquid phase separation upon binding to mRNAs containingmultiple m6A-modified residues: polymethylated mRNAs act as amultivalent scaffold for the binding of YTHDF proteins, juxtaposingtheir disordered regions and thereby leading to phase separation. The resulting mRNA-YTHDF complexes then partition into differentendogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules. May alsorecognize and bind RNAs modified by C5-methylcytosine (m5C) and act asa regulator of rRNA processing.
                            
                            
              
                            
              
                            
              
                            
              
                            
              
                            
              
                            
              
                            
              
                            
              
                            [1-10]
              
                               Click to Show/Hide | ||||||||
| 3D Structure |  | ||||||||
| Function of This Protein During Virus Infection | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Virus Name | SARS-COV-2 | Protein Function | Anti-viral | [11] | |||||
| Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
| Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
| Method Description | To detect the role of host protein YTHDF2 in viral infection, YTHDF2 protein Knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
| Results | It is reported that knockout of YTHDF2 increases SARS-CoV-2 RNA levels compared with control group. | ||||||||
| Host Protein - Virus RNA Network | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Full List of Virus RNA Interacting with This Protien | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNA Region: Not Specified Virus Region (hCoV-19/Not Specified Virus Strain ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [12] | |||||||
| Strains Name | hCoV-19/Not Specified Virus Strain 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | Huh7 cells (liver carcinoma cell) (CVCL_0336 ) | ||||||||
| Cell Originated Tissue | Liver | ||||||||
| Infection Time | 24h | ||||||||
| Interaction Score | log2FC = 1.15863E+14 | ||||||||
| Method Description | RNA antisense purification and quantitative mass spectrometry (RAP-MS); Tandem mass tag (TMT) labelling; liquid chromatography tandem mass spectrometry (LC-MS/MS); Westernblot | ||||||||
| RNA Region: Not Specified Virus Region (hCoV-19/England/02/2020 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [13] | |||||||
| Strains Name | hCoV-19/England/02/2020 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | Calu-3 cells (Human lung cancer cell) Calu-3 cells (Human lung cancer cell) (CVCL_0609 ) | ||||||||
| Cell Originated Tissue | Lung | ||||||||
| Infection Time | 24 h | ||||||||
| Interaction Score | P-adjust = 0.006 | ||||||||
| Method Description | UV protein-RNA crosslinking; RNA interactome capture (cRIC); RNA antisense purification coupled with mass spectrometry (RAP-MS) | ||||||||

 Home
 Home Search
 Search 
 Browse
 Browse  Download
 Download Manual
 Manual

